ADVISORY/MGI PHARMA To Present At the UBS Warburg Global Specialty Pharmaceuticals Conference.News/Assignment Editors & Medical Writers ADVISORY...for Thursday (June 6) MINNEAPOLIS--(BUSINESS WIRE)--May 29, 2002 -- June 6, 2002 Webcast -- MGI MGI Mouse Genome Informatics MGI Modular Gateway Interface MGI McKinsey Global Institute MGI Military Geographic Information MGI Marine Geological Institute MGI Policy on the Management of Government Information (Canada) PHARMA, Inc., (Nasdaq:MOGN) today announced that it will participate in the UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Warburg Global Specialty Pharmaceuticals Conference on Thursday, June 6, 2002, at 8:30 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy . MGI's presentation will be webcast live over the Internet. Lonnie Moulder moul·der v. Chiefly British Variant of molder. moulder or US molder Verb to crumble or cause to crumble, as through decay: , president and COO of MGI PHARMA will give the presentation. The two-day conference will be held at the Grand Hyatt Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. .
What: MGI PHARMA's presentation at the UBS Warburg Conference
When: Thursday, June 6, 2002 at 8:30 a.m. Eastern Time
Where: www.mgipharma.com
How: Click on the webcast link on the MGI PHARMA home page. Find
the Conference Highlights link on the right hand side of the
page. Click on the link. Follow link for Live Audio under the
Global Specialty Pharmaceuticals heading. The presentation
will be archived on the site until July 6, 2002.
About MGI PHARMA MGI PHARMA, Inc. is an oncology-focused pharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. MGI has a balanced product portfolio of proprietary pharmaceuticals, and intends to become a leader in oncology. The company focuses its sales efforts solely in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and collaborates with other pharmaceutical or biotechnology companies for its products in international markets. For more information about MGI, please visit the company's Web site at www.mgipharma.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion